I’m not sure what happened to the the original text, therefore here comes my second attempt..
I recently made two investments in tiny Alzheimer’s biotech companies: Promis Neurosciences ($PMN.TO) and Neurotrope ($NTRP $NTRPD). I’m interested in making more investment in the real estate located at the intersection of Toxic Oligomers (prions)/Tau/Synapses Regeneration. I explain the rational in a post titled Help Me Identify Alzheimer’s Microcaps Winners:
I do believe Neurotrope Phase 2b topline Readout due in April and Promis Neurosciences cohort study results due in Q2 ( http://biggercapital.squarespace.com/biggercapital-investment/2017/1/9/an-alzheimers-watershed-event-on-our-doorstep.html) could turn the Alzheimer’s world on its head.
If you know any tiny companies with great MOAs operating on that real estate, please let me know. There is a Swedish biotech company I’m following closely: Alzinova. I will be meeting the CEO at the AAIC in London this summer. If you attend, let’s meetup. If you know anything about this company please let me know. I don’t have an investment.
I usually invest directly into companies. I’m also a cheap bastard!
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.